| __timestamp | Amphastar Pharmaceuticals, Inc. | Novartis AG |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 14993000000 |
| Thursday, January 1, 2015 | 46974000 | 14247000000 |
| Friday, January 1, 2016 | 47298000 | 14192000000 |
| Sunday, January 1, 2017 | 50918000 | 14997000000 |
| Monday, January 1, 2018 | 58044000 | 16471000000 |
| Tuesday, January 1, 2019 | 63109000 | 14369000000 |
| Wednesday, January 1, 2020 | 65157000 | 14197000000 |
| Friday, January 1, 2021 | 68920000 | 14886000000 |
| Saturday, January 1, 2022 | 66592000 | 14253000000 |
| Sunday, January 1, 2023 | 80393000 | 12489000000 |
| Monday, January 1, 2024 | 12566000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Over the past decade, from 2014 to 2023, Novartis AG and Amphastar Pharmaceuticals, Inc. have shown distinct patterns in their Selling, General, and Administrative (SG&A) expenses. Novartis, a global leader, consistently reported SG&A expenses averaging around $14.5 billion annually, with a notable peak in 2018. In contrast, Amphastar, a smaller player, exhibited a steady increase, culminating in a 99% rise from 2014 to 2023. This divergence highlights the scale and strategic differences between a pharmaceutical giant and a growing company. While Novartis's expenses reflect its expansive operations, Amphastar's growth trajectory suggests strategic investments in scaling operations. These insights offer a window into the financial strategies shaping the pharmaceutical landscape.
Who Optimizes SG&A Costs Better? Novartis AG or Dr. Reddy's Laboratories Limited
Novartis AG or Bio-Techne Corporation: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Novartis AG vs Pharming Group N.V. Trends and Insights
Novartis AG and ACADIA Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Novartis AG and Perrigo Company plc
GSK plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Ultragenyx Pharmaceutical Inc. vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Arrowhead Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.
Comparing SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs MannKind Corporation Trends and Insights